We are live on ! Find out more
BL

BFSG LLC Portfolio holdings

AUM $1.13B
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+29.95%
3 Year Est. Return
+81.86%
5 Year Est. Return
+99.93%
10 Year Est. Return
AUM
$789M
AUM Growth
+$31.9M
Cap. Flow
+$17.6M
Cap. Flow %
2.24%
Top 10 Hldgs %
25.03%
Holding
689
New
25
Increased
129
Reduced
217
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 16.08%
2 Industrials 9.63%
3 Healthcare 6.96%
4 Consumer Staples 6.77%
5 Consumer Discretionary 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHAT icon
551
Phathom Pharmaceuticals
PHAT
$912M
$3.09K ﹤0.01%
300
ENZ
552
DELISTED
Enzo Biochem, Inc.
ENZ
$3.07K ﹤0.01%
2,813
DVY icon
553
iShares Select Dividend ETF
DVY
$24B
$3.02K ﹤0.01%
25
-30
-55% -$3.64K
LEN.B icon
554
Lennar Class B
LEN.B
$20B
$3.02K ﹤0.01%
23
AFRM icon
555
Affirm
AFRM
$23.5B
$3.02K ﹤0.01%
100
CAMT icon
556
Camtek
CAMT
$6.9B
$3.01K ﹤0.01%
24
ZM icon
557
Zoom
ZM
$25.8B
$2.96K ﹤0.01%
50
ESGV icon
558
Vanguard ESG US Stock ETF
ESGV
$12.9B
$2.9K ﹤0.01%
30
-2
-6% -$185
HPE icon
559
Hewlett Packard
HPE
$63.2B
$2.81K ﹤0.01%
133
AZN icon
560
AstraZeneca
AZN
$263B
$2.81K ﹤0.01%
18
IWV icon
561
iShares Russell 3000 ETF
IWV
$19.5B
$2.78K ﹤0.01%
9
-31
-78% -$9.25K
CHWY icon
562
Chewy
CHWY
$8.54B
$2.72K ﹤0.01%
100
DOCU
563
DocuSign
DOCU
$9.63B
$2.67K ﹤0.01%
50
ARWR icon
564
Arrowhead Research
ARWR
$12.1B
$2.6K ﹤0.01%
100
SPYM
565
State Street SPDR Portfolio S&P 500 ETF
SPYM
$158B
$2.56K ﹤0.01%
40
CLRB icon
566
Cellectar Biosciences
CLRB
$19.3M
$2.5K ﹤0.01%
33
VGK icon
567
Vanguard FTSE Europe ETF
VGK
$30B
$2.47K ﹤0.01%
+37
New +$2.51K
TELA icon
568
TELA Bio
TELA
$30.9M
$2.47K ﹤0.01%
525
JMIA
569
Jumia Technologies
JMIA
$726M
$2.46K ﹤0.01%
350
MRNA icon
570
Moderna
MRNA
$21.5B
$2.38K ﹤0.01%
20
AVDV icon
571
Avantis International Small Cap Value ETF
AVDV
$18.9B
$2.34K ﹤0.01%
+36
New +$2.38K
TLT icon
572
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$2.29K ﹤0.01%
25
-290
-92% -$26.4K
INZY
573
DELISTED
Inozyme Pharma
INZY
$2.23K ﹤0.01%
500
BIL icon
574
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
$2.2K ﹤0.01%
24
SABR icon
575
Sabre
SABR
$656M
$2.14K ﹤0.01%
800

Similar funds

BFSG LLC's Q2 2024 Portfolio in Review

As of Q2 2024, BFSG LLC held 689 positions worth $789M, up 4.2% from $757M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

BFSG LLC's Q2 2024 filing shows 25 new, 129 increased, 217 reduced and 65 closed positions. Its largest new stake was Enterprise Products Partners: 180,787 shares worth $5.24M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $5.52M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • BFSG LLC's largest Q2 2024 buy was Enterprise Products Partners: 180,787 shares worth $5.24M.
  • BFSG LLC added most to Marvell Technology in Q2 2024, an estimated $7.71M increase.
  • BFSG LLC's biggest Q2 2024 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $5.52M.
  • BFSG LLC fully exited Franco-Nevada in Q2 2024, selling an estimated $3.87M.
  • BFSG LLC's ten largest holdings make up 25% of its $789M portfolio in Q2 2024.
  • BFSG LLC opened 25 new positions and closed 65 in Q2 2024.
  • BFSG LLC's portfolio value rose 4.2% quarter-over-quarter to $789M.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.